Science Explorer Back to mapMap
Discussion
Topic · Physiology

Biomedical Ethics and Regulation

Biomedical Ethics and Regulation is a research topic within Physiology. Science Explorer counts 25k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the regulation, ethical considerations, and challenges surrounding stem cell therapies and clinics. It covers topics such as patient safety, direct-to-consumer marketing, global governance, translational research, and the ethical implications of unproven therapies. The papers also discuss the need for comprehensive regulatory frameworks to ensure the safe and ethical development of regenerative medicine.

  • Stem Cell Regulation
  • Clinical Trials
  • Regulatory Challenges
  • Patient Safety
  • Direct-to-Consumer Marketing
  • Ethical Issues
  • Global Governance
  • Translational Research
  • Unproven Therapies
  • Regenerative Medicine
Research works
25k
fractional, since 1950
In the world top 10%
2.6k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+19%
the tick is no change
Largest producer
United States
47% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Biomedical Ethics and Regulation research?

By volume, the United States and the United Kingdom publish the most (1.9k and 452 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.9k works
  2. 2 United Kingdom 452 works
  3. 3 China 356 works
  4. 4 India 295 works
  5. 5 Germany 193 works
  6. 6 Canada 175 works
  7. 7 France 173 works
  8. 8 Japan 155 works
  9. 9 Italy 153 works
  10. 10 Australia 145 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 47.1%United Kingdom: 11.4%China: 9.0%India: 7.4%6 others listed: 25.1%47%largest
United States1,867 · 47.1%United Kingdom452 · 11.4%China356 · 9.0%India295 · 7.4%6 others listed994 · 25.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Biomedical Ethics and Regulation research?

By volume in 2022-now, Harvard University publishes the most Biomedical Ethics and Regulation research, followed by BMJ Group (United Kingdom) and University of North Carolina at Chapel Hill.

Who are the leading researchers in Biomedical Ethics and Regulation?

The most-cited researchers publishing on Biomedical Ethics and Regulation include David Moher, Douglas G. Altman and Zulfiqar Ahmed Bhutta.

  1. 1 David Moher Canada 898k citations
  2. 2 Douglas G. Altman United Kingdom 862k citations
  3. 3 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  4. 4 Cyrus Cooper United Kingdom 342k citations
  5. 5 Giuseppe Remuzzi Italy 328k citations
  6. 6 John P. A. Ioannidis United States 317k citations
  7. 7 Gordon Henry Guyatt Canada 315k citations
  8. 8 Elie A. Akl Canada 313k citations
  9. 9 Dan J. Stein South Africa 306k citations
  10. 10 Róbert Langer United States 303k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Biomedical Ethics and Regulation?

The most cited paper in Biomedical Ethics and Regulation is "ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells" (Daniel W. Lee et al., 2018), with 3,663 citations. Next come "Bone marrow transplant" (3,412) and "Raise standards for preclinical cancer research" (2,968).

Most cited papers
#PaperReleasedCitations
1 ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells Daniel W. Lee et al. · Transplantation and Cellular Therapy Open access 25 Dec 2018 3,663
2 Bone marrow transplant Angela Joyce · Nursing Children and Young People Sep 1989 3,412
3 Raise standards for preclinical cancer research C. Glenn Begley, Lee M. Ellis · Nature Open access 27 Mar 2012 2,968
4 The Belmont Report: ethical principles and guidelines for the protection of human subjects of research Sue Eckstein · Cambridge University Press eBooks Book chapterOpen access 20 Feb 2003 2,712
5 What Makes Clinical Research Ethical? Ezekiel J. Emanuel · JAMA 24 May 2000 2,701
All 100 most cited papers, with filters and sorting

Where is Biomedical Ethics and Regulation research done?

The largest centres of Biomedical Ethics and Regulation research in 2022-now are London (United Kingdom), New York (United States), Beijing (China) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in London, Silver Spring and San Francisco.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 161 works
  2. 2 New YorkUnited States 101 works
  3. 3 BeijingChina 84 works
  4. 4 BostonUnited States 76 works
  5. 5 Washington D.C.United States 67 works
  6. 6 ParisFrance 66 works
  7. 7 TokyoJapan 61 works
  8. 8 CambridgeUnited States 58 works
  9. 9 HoustonUnited States 45 works
  10. 10 TorontoCanada 45 works

Where it is the local speciality

  1. London43.1 works52×
  2. Silver SpringUS · 23.2 works21×
  3. San FranciscoUS · 35.9 works5.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Biomedical Ethics and Regulation than the world average.

See Biomedical Ethics and Regulation on the map

Where is the best place to study Biomedical Ethics and Regulation?

Among universities, judged by research, Harvard University, Utrecht University and Erasmus University Rotterdam score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 15.65%fractional works in this field (log) →share of work in the world top 10% →Utrecht UniversityErasmus University R…University of Califo…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 76.914.7%5.6×83 +24.5%
2Utrecht UniversityNetherlands 67.026.1%4.8×16 -5.8%
3Erasmus University RotterdamNetherlands 63.123.0%5.2×12 +62.1%
4University of California, San FranciscoUnited States 59.718.1%5.3×18 +28.0%
5Stanford UniversityUnited States 55.711.9%5.1×35 +4.8%
6Johns Hopkins UniversityUnited States 54.513.7%3.5×25 +15.0%
7Leiden UniversityNetherlands 53.418.5%4.5×11 +43.5%
8University College LondonUnited Kingdom 52.94.3%4.4×33 +114.9%
9University of TorontoCanada 52.310.5%2.8×26 +28.3%
10The University of MelbourneAustralia 51.215.7%3.4×18 +11.8%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Biomedical Ethics and Regulation, country by country

Is Biomedical Ethics and Regulation research growing?

Output in 2022-2025 was 19% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Biomedical Ethics and Regulation.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biomedical Ethics and Regulation as a percentage of every work published that year, 0.024% in 2024.

still counting0.010%0.020%0.030%Biomedical Ethics and Regulation0.026% in 202519801990200020102020

Fractional works of Biomedical Ethics and Regulation over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Biomedical Ethics and Regulation10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Biomedical Ethics and Regulation. Posts are plain text and can be reported.